The Computer-aided Detection (CAD) Market is projected to reach $1.56 billion by 2031, at a CAGR of 7.4% from 2024 to 2031. Computer-aided detection is utilized in the categorization and identification of benign and malignant lesions. It assists vascular physicians in deciding the most effective treatments for patients with cardiovascular diseases using techniques such as mammography, ultrasound, and MRI. CAD technologies enhance radiologists' ability to detect and distinguish between normal and abnormal (cancerous) tissues. Furthermore, CAD is used to detect and diagnose various cancers, including breast, lung, and liver cancers. It reduces the chances of false negative/positive results in disease diagnosis.
The growth of the CAD market is driven by the rising prevalence of chronic diseases, increasing awareness regarding the importance of early cancer diagnosis, increasing investments and funding for cancer research, and rising healthcare expenditures. However, the high costs of CAD solutions restrain the growth of this market.
Additionally, the growing acceptance of CAD among radiologists, the increase in cancer screening programs, and advancements in CAD solutions, such as the integration of Artificial Intelligence (AI) and Machine Learning (ML), are expected to generate market growth opportunities. However, the lack of technical expertise required for using CAD systems is a significant challenge impacting the market's growth.
In recent years, the growing prevalence of cancer and the associated mortalities have raised awareness about the importance of early cancer diagnosis. A significant number of cancer cases are diagnosed in advanced stages, primarily due to a lack of awareness. Numerous organizations are actively undertaking initiatives such as awareness programs and campaigns to promote early cancer detection. These initiatives highlight the risks associated with cancer and emphasize the significance of timely and regular cancer diagnoses. Some of the initiatives are as follows:
In November 2023, Apollo Cancer Centre (India) launched a breast cancer diagnosis program to provide rapid and accurate breast cancer diagnoses, highlighting the importance of early detection in selecting the right treatments for a higher survival rate and improving patients' quality of life.
Thus, increasing awareness regarding the importance of early cancer diagnosis is boosting the adoption of CAD solutions.
-Market.webp "Computer-aided Detection (CAD) Market")
Click here to: Get Free Sample Pages of this Report
Government and healthcare organizations around the world are launching cancer screening programs and campaigns to raise awareness and reduce the global burden of cancer. For instance:
In September 2023, the Government of New Brunswick (Canada) launched a lung cancer screening program to screen high-risk patients. Under this program, the Government of New Brunswick has invested $3.4 million to support lung cancer screening.
This increase in cancer screening programs is expected to boost the adoption of CAD solutions, generating market growth opportunities.
Based on application, in 2024, the oncology segment is expected to account for the largest share of the computer-aided detection market. The segment’s large share is attributed to the increasing prevalence of breast cancer and the increase in breast cancer detection and awareness campaigns. Breast cancer ranks among the most prevalent cancers affecting women globally. According to the World Health Organization (WHO), 2.3 million breast cancer cases were recorded globally in 2020, and this number is expected to reach 3 million by 2040. The rising incidence of breast cancer has led to a rapid increase in the adoption of innovative technologies, such as CAD, aimed at enhancing breast cancer detection through a combination of various modalities.
Based on imaging modality, in 2024, the mammography segment is expected to account for the largest share of the computer-aided detection market. The segment’s large share is attributed to the introduction of advanced mammography systems with cutting-edge technologies and the growing use of computer-aided detection in multispecialty hospitals. CAD technology improves patient outcomes by increasing the precision of mammography readings and decreasing the risk of false positives. Furthermore, the growth in breast cancer screening programs in developed countries also contributes to the segment’s large share.
Based on end user, in 2024, the hospitals & clinics segment is expected to account for the largest share of the computer-aided detection market. The segment’s large share is attributed to the rising prevalence of cancer, the growing number of hospitals and clinics, the availability of highly skilled professionals in hospitals and clinics, the high purchasing power of hospitals, and the increasing patient population seeking comprehensive healthcare services, including diagnosis, treatment, and surgical procedures.
Based on geography, Asia-Pacific is expected to record the highest CAGR during the forecast period. The growth of this regional market is driven by rising breast cancer cases, growing awareness regarding the importance of early diagnosis and detection of cancer, cardiovascular diseases, and neurological disorders, the increase in cancer screening programs, the expansion of the healthcare sector, and increasing government investments and initiatives supporting cancer research.
This report includes a competitive landscape based on an extensive assessment of the product offerings and geographic presence of leading market players and the key growth strategies adopted by them in the last three to four years. The key players profiled in the computer-aided detection market report are Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (U.S.), Hologic, Inc. (U.S.), FUJIFILM Holdings Corporation (Japan), EDDA Technology, Inc. (U.S.), Canon Medical Systems Corporation (Japan), Riverain Technologies (U.S.), Median Technologies (France), Agfa-Gevaert NV (Belgium), iCAD Inc. (U.S.), CureMetrix, Inc. (U.S.), and THERAPIXEL (France).
Computer-aided Detection (CAD) Market Report Summary :
|
Particulars |
Details |
|
No. of Pages |
260 |
|
Format |
|
|
Forecast Period |
2024–2031 |
|
Base Year |
2023 |
|
CAGR |
7.4% |
|
Market Size (Value) |
$1.56 Billion |
|
Segments Covered |
By Application
By Imaging Modality
By End User
|
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, Italy, U.K., Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa |
|
Companies Profiled |
Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (U.S.), Hologic, Inc. (U.S.), FUJIFILM Holdings Corporation (Japan), EDDA Technology, Inc. (U.S.), Canon Medical Systems Corporation (Japan), Riverain Technologies (U.S.), Median Technologies (France), Agfa-Gevaert NV (Belgium), iCAD Inc. (U.S.), CureMetrix, Inc. (U.S.), and THERAPIXEL (France) |
This study provides a detailed assessment of the Computer-aided Detection (CAD) market and includes market sizes & forecasts based on application, imaging modality, and end user. The report also provides a value analysis for various segments and subsegments of the Computer-aided Detection (CAD) market at the regional and country levels.
The Computer-aided Detection (CAD) market is projected to reach $1.56 billion by 2031, at a CAGR of 7.4% during the forecast period 2024–2031.
Based on application, in 2024, the oncology segment is expected to account for the largest share of the CAD market. The segment’s large share is attributed to the increasing prevalence of breast cancer, rising awareness regarding cancer diagnosis, and growth in cancer screening programs.
The growth of this market is driven by the rising prevalence of chronic diseases, increasing awareness regarding the importance of early cancer diagnosis, increasing investments and funding for cancer research, and rising healthcare expenditures. Additionally, the growing acceptance of CAD among radiologists, the increase in cancer screening programs, and advancements in CAD solutions, such as the integration of Artificial Intelligence (AI) and Machine Learning (ML), are expected to generate significant market growth opportunities.
The key players profiled in this report are Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (U.S.), Hologic, Inc. (U.S.), FUJIFILM Holdings Corporation (Japan), EDDA Technology, Inc. (U.S.), Canon Medical Systems Corporation (Japan), Riverain Technologies (U.S.), Median Technologies (France), Agfa-Gevaert NV (Belgium), iCAD Inc. (U.S.), CureMetrix, Inc. (U.S.), and THERAPIXEL (France).
Emerging economies, such as China and India, are expected to generate significant growth opportunities for market players due to the increasing government R&D spending in these countries.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Data Collection and Validation Process
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Rising Prevalence of Chronic Diseases
4.2.2. Increasing Awareness Regarding the Importance of Early Cancer Diagnosis
4.2.3. Increasing Investments and Funding for Cancer Research
4.2.4. Rising Healthcare Expenditures
4.3. Restraints
4.3.1. High Costs of CAD Solutions
4.4. Opportunities
4.4.1. Growing Acceptance of CAD Among Radiologists
4.4.2. Increase in Cancer Screening Programs
4.4.3. Integration of Artificial Intelligence (AI) and Machine Learning (ML) into CAD Solutions
4.5. Challenges
4.5.1. Lack of Technical Expertise Required to Use CAD Systems
4.6. Factor Analysis
4.7. Pricing Analysis
4.8. Market/Industry Trends
4.9. Porter’s Five Forces Analysis
5. Computer-aided Detection (CAD) Market Assessment—by Application
5.1. Overview
5.2. Oncology
5.2.1. Breast Cancer
5.2.2. Lung Cancer
5.2.3. Liver Cancer
5.2.4. Colon/Rectal Cancer
5.2.5. Prostate Cancer
5.2.6. Bone Cancer
5.2.7. Other Cancer Types
5.3. Cardiology
5.4. Other Applications
6. Computer-aided Detection (CAD) Market Assessment—by Imaging Modality
6.1. Overview
6.2. Mammography
6.3. Magnetic Resonance Imaging (MRI)
6.4. Computed Tomography (CT)
6.5. Ultrasound Imaging
6.6. Other Imaging Modality
7. Computer-aided Detection (CAD) Market Assessment—by End User
7.1. Overview
7.2. Hospitals & Clinics
7.3. Diagnostic Imaging Centers
7.4. Ambulatory Care and Surgery Centers
8. Computer-aided Detection (CAD) Market Assessment—by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Rest of Asia-Pacific
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Latin America
8.6. Middle East & Africa
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Key Players’ Market Share Analysis/Market Rankings (2023)
10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
10.1. Siemens Healthineers AG
10.2. Koninklijke Philips N.V.
10.3. GE HealthCare Technologies Inc.
10.4. Hologic, Inc.
10.5. FUJIFILM Holdings Corporation
10.6. EDDA Technology, Inc.
10.7. Canon Medical Systems Corporation
10.8. Riverain Technologies
10.9. Median Technologies
10.10. Agfa-Gevaert NV
10.11. iCAD Inc.
10.12. CureMetrix, Inc.
10.13. THERAPIXEL
(Note: SWOT analyses of the top 5 companies will be provided.)
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1 Global Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 2 Global Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 3 Global Computer-aided Detection (CAD) Market for Breast Cancer, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Computer-aided Detection (CAD) Market for Lung Cancer, by Country/Region, 2022–2031 (USD Million)
Table 5 Global Computer-aided Detection (CAD) Market for Liver Cancer, by Country/Region, 2022–2031 (USD Million)
Table 6 Global Computer-aided Detection (CAD) Market for Colon/Rectal Cancer, by Country/Region, 2022–2031 (USD Million)
Table 7 Global Computer-aided Detection (CAD) Market for Prostate Cancer, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Computer-aided Detection (CAD) Market for Bone Cancer, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Computer-aided Detection (CAD) Market for Other Cancer Types, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Computer-aided Detection (CAD) Market for Cardiology, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Computer-aided Detection (CAD) Market for Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 13 Global Computer-aided Detection (CAD) Market for Mammography, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Computer-aided Detection (CAD) Market for Magnetic Resonance Imaging (MRI), by Country/Region, 2022–2031 (USD Million)
Table 15 Global Computer-aided Detection (CAD) Market for Computed Tomography (CT), by Country/Region, 2022–2031 (USD Million)
Table 16 Global Computer-aided Detection (CAD) Market for Ultrasound Imaging by Country/Region, 2022–2031 (USD Million)
Table 17 Global Computer-aided Detection (CAD) Market for Other Imaging Modalities, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 19 Global Computer-aided Detection (CAD) Market for Hospitals & Clinics, by Country/Region, 2022–2031 (USD Million)
Table 20 Global Computer-aided Detection (CAD) Market for Diagnostic Imaging Centers, by Country/Region, 2022–2031 (USD Million)
Table 21 Global Computer-aided Detection (CAD) Market for Ambulatory Care and Surgery Centers, by Country/Region, 2022–2031 (USD Million)
Table 22 Global Computer-aided Detection (CAD) Market, by Country/Region, 2022–2031 (USD Million)
Table 23 North America: Computer-aided Detection (CAD) Market, by Country, 2022–2031 (USD Million)
Table 24 North America: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 25 North America: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 26 North America: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 27 North America: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 28 U.S.: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 29 U.S.: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 30 U.S.: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 31 U.S.: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 32 Canada: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 33 Canada: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 34 Canada: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 35 Canada: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 36 Europe: Computer-aided Detection (CAD) Market, by Country/Region, 2022–2031 (USD Million)
Table 37 Europe: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 38 Europe: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 39 Europe: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 40 Europe: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 41 Germany: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 42 Germany: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 43 Germany: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 44 Germany: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 45 France: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 46 France: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 47 France: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 48 France: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 49 Italy: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 50 Italy: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 51 Italy: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 52 Italy: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 53 U.K.: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 54 U.K.: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 55 U.K.: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 56 U.K.: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 57 Spain: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 58 Spain: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 59 Spain: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 60 Spain: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 61 Rest of Europe: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 62 Rest of Europe: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 63 Rest of Europe: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 64 Rest of Europe: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 65 Asia-Pacific: Computer-aided Detection (CAD) Market, by Country/Region, 2022–2031 (USD Million)
Table 66 Asia-Pacific: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 67 Asia-Pacific: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 68 Asia-Pacific: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 69 Asia-Pacific: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 70 Japan: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 71 Japan: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 72 Japan: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 73 Japan: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 74 China: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 75 China: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 76 China: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 77 China: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 78 India: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 79 India: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 80 India: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 81 India: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 82 Rest of Asia-Pacific: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 83 Rest of Asia-Pacific: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 84 Rest of Asia-Pacific: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 85 Rest of Asia-Pacific: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 86 Latin America: Computer-aided Detection (CAD) Market, by Country/Region, 2022–2031 (USD Million)
Table 87 Latin America: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 88 Latin America: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 89 Latin America: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 90 Latin America: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 91 Brazil: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 92 Brazil: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 93 Brazil: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 94 Brazil: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 95 Mexico: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 96 Mexico: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 97 Mexico: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 98 Mexico: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 99 Rest of Latin America: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 100 Rest of Latin America: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 101 Rest of Latin America: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 102 Rest of Latin America: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 103 Middle East & Africa: Computer-aided Detection (CAD) Market, by Application, 2022–2031 (USD Million)
Table 104 Middle East & Africa: Computer-aided Detection (CAD) Market for Oncology, by Type, 2022–2031 (USD Million)
Table 105 Middle East & Africa: Computer-aided Detection (CAD) Market, by Imaging Modality, 2022–2031 (USD Million)
Table 106 Middle East & Africa: Computer-aided Detection (CAD) Market, by End User, 2022–2031 (USD Million)
Table 107 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Computer-aided Detection (CAD) Market, by Application, 2024 VS. 2031 (USD Million)
Figure 8 Global Computer-aided Detection (CAD) Market, by Imaging Modality, 2024 VS. 2031 (USD Million)
Figure 9 Global Computer-aided Detection (CAD) Market, by End User, 2024 VS. 2031 (USD Million)
Figure 10 Global Computer-aided Detection (CAD) Market, by Geography
Figure 11 Impact Analysis: Computer-aided Detection (CAD) Market
Figure 12 Global Computer-aided Detection (CAD) Market, by Application, 2024 VS. 2031 (USD Million)
Figure 13 Global Computer-aided Detection (CAD) Market, by Imaging Modality, 2024 VS. 2031 (USD Million)
Figure 14 Global Computer-aided Detection (CAD) Market, by End User, 2024 VS. 2031 (USD Million)
Figure 15 Global Computer-aided Detection (CAD) Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 16 North America: Computer-aided Detection (CAD) Market Snapshot
Figure 17 Europe: Computer-aided Detection (CAD) Market Snapshot
Figure 18 Asia-Pacific: Computer-aided Detection (CAD) Market Snapshot
Figure 19 Latin America: Computer-aided Detection (CAD) Market Snapshot
Figure 20 Key Growth Strategies Adopted by Leading Players, 2021–2024
Figure 21 Global Computer-aided Detection (CAD) Market: Vendor Dashboard
Figure 22 Global Computer-aided Detection (CAD) Market: Competitive Benchmarking, by Application
Figure 23 Global Computer-aided Detection (CAD) Market: Competitive Benchmarking, by Geography
Figure 24 Market Share Analysis: Global Computer-aided Detection (CAD) Market (2023)
Figure 25 Siemens Healthineers AG: Financial Overview (2022)
Figure 26 Koninklijke Philips N.V.: Financial Overview (2022)
Figure 27 GE HealthCare Technologies Inc: Financial Overview (2022)
Figure 28 Hologic, Inc: Financial Overview (2022)
Figure 29 FUJIFILM Holdings Corporation: Financial Overview (2022)
Figure 30 Canon Medical Systems Corporation: Financial Overview (2022)
Figure 31 Median Technologies: Financial Overview (2022)
Figure 32 Agfa-Gevaert NV: Financial Overview (2022)
Figure 33 iCAD Inc.: Financial Overview (2022)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: May-2023
Published Date: Nov-2017
Published Date: Apr-2024
